By analysing the clinical data of CRC patients and COCN, the results showed that higher results for these indicators indicate worse tumour biological behaviours and worse body conditions in patients with CRC, suggesting that the high COCN group might have a worse prognosis, which was consistent with the conclusions obtained from the analysis of CIP2A and the NLR. The gene discussed is CIP2A; the disease is neoplasm.